{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:34:03Z","timestamp":1790825643397,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["HA6736\/1-1"],"award-info":[{"award-number":["HA6736\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["P30-AR057217"],"award-info":[{"award-number":["P30-AR057217"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["R01-AR052672"],"award-info":[{"award-number":["R01-AR052672"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1038\/jid.2014.291","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T10:53:03Z","timestamp":1408618383000},"page":"742-749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Persistence of Anti-Desmoglein 3 IgG+ B-Cell Clones in Pemphigus Patients over Years"],"prefix":"10.1016","volume":"135","author":[{"given":"Christoph M.","family":"Hammers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Kacir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don L.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee S.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2014.291_bb0010","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nm.3163","article-title":"Of men, not mice","volume":"19","author":"Anonymous","year":"2013","journal-title":"Nat Med"},{"key":"10.1038\/jid.2014.291_bb0015","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"355","author":"Ahmed","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2014.291_bb0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaad.2013.05.016","article-title":"Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids","volume":"69","author":"Almugairen","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2014.291_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI117349","article-title":"Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus","volume":"94","author":"Amagai","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2014.291_bb0030","series-title":"Phage Display: A Laboratory Manual","author":"Barbas","year":"2001"},{"key":"10.1038\/jid.2014.291_bb0035","doi-asserted-by":"crossref","first-page":"175ra30","DOI":"10.1126\/scitranslmed.3005166","article-title":"Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response","volume":"5","author":"Colliou","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1038\/jid.2014.291_bb0040","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.immuni.2008.12.003","article-title":"A prescription for human immunology","volume":"29","author":"Davis","year":"2008","journal-title":"Immunity"},{"key":"10.1038\/jid.2014.291_bb0045","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1172\/JCI64413","article-title":"Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface","volume":"122","author":"Di Zenzo","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2014.291_bb0050","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1038\/jid.2008.172","article-title":"Rituximab exerts a dual effect in pemphigus vulgaris","volume":"128","author":"Eming","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.291_bb0055","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1517\/21678707.2013.775933","article-title":"Contemporary management of pemphigus","volume":"1","author":"Hammers","year":"2013","journal-title":"Expert Opin Orphan Drugs"},{"key":"10.1038\/jid.2014.291_bb0060","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1038\/jid.2013.521","article-title":"Antibody phage display: technique and applications","volume":"134","author":"Hammers","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.291_bb0065","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/annrheumdis-2011-201189","article-title":"Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjogren's syndrome after B cell depletion therapy","volume":"71","author":"Hamza","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/jid.2014.291_bb0070","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.159.4.2010","article-title":"Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins","volume":"159","author":"Ishii","year":"1997","journal-title":"J Immunol"},{"key":"10.1038\/jid.2014.291_bb0075","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.jid.5701132","article-title":"Isolation of pathogenic monoclonal anti-desmoglein 1 human antibodies by phage display of pemphigus foliaceus autoantibodies","volume":"128","author":"Ishii","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.291_bb0080","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2014.291_bb0085","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.clindermatol.2011.03.014","article-title":"Current therapy of the pemphigus group","volume":"30","author":"Kasperkiewicz","year":"2012","journal-title":"Clin Dermatol"},{"key":"10.1038\/jid.2014.291_bb0090","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1172\/JCI68775","article-title":"Specific peripheral B cell tolerance defects in patients with multiple sclerosis","volume":"123","author":"Kinnunen","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2014.291_bb0095","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jaad.2012.08.010","article-title":"Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: a retrospective study of 47 patients","volume":"68","author":"Leshem","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2014.291_bb0100","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archdermatol.2012.1522","article-title":"Adjuvant rituximab therapy of pemphigus: a single-center experience with 31 patients","volume":"148","author":"Lunardon","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2014.291_bb0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2010.05877.x","article-title":"B cell receptor editing in tolerance and autoimmunity","volume":"1217","author":"Luning Prak","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1038\/jid.2014.291_bb0110","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1172\/JCI5252","article-title":"Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris","volume":"103","author":"Mahoney","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2014.291_bb0115","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.4049\/jimmunol.166.6.4170","article-title":"Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease","volume":"166","author":"Marzari","year":"2001","journal-title":"J Immunol"},{"key":"10.1038\/jid.2014.291_bb0120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/clin.1997.4408","article-title":"Mechanisms of acantholysis in pemphigus vulgaris: role of IgG valence","volume":"85","author":"Mascaro","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1038\/jid.2014.291_bb0125","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1172\/JCI58743","article-title":"Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity","volume":"122","author":"Maurer","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2014.291_bb0130","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J Immunol"},{"key":"10.1038\/jid.2014.291_bb0135","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1038\/jid.2008.178","article-title":"B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses","volume":"128","author":"Mouquet","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.291_bb0140","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus","volume":"58","author":"Murrell","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2014.291_bb0145","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ceb.2004.07.006","article-title":"Desmosomes and disease: pemphigus and bullous impetigo","volume":"16","author":"Payne","year":"2004","journal-title":"Curr Opin Cell Biol"},{"key":"10.1038\/jid.2014.291_bb0150","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1172\/JCI24185","article-title":"Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display","volume":"115","author":"Payne","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2014.291_bb0155","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.4049\/jimmunol.178.9.5982","article-title":"Dissecting the anti-desmoglein autoreactive B cell repertoire in pemphigus vulgaris patients","volume":"178","author":"Qian","year":"2007","journal-title":"J Immunol"},{"key":"10.1038\/jid.2014.291_bb0160","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1523-1747.1998.00085.x","article-title":"Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1","volume":"110","author":"Shirakata","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.291_bb0165","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.4049\/jimmunol.0901691","article-title":"Antibodies to the desmoglein 1 precursor proprotein but not to the mature cell surface protein cloned from individuals without pemphigus","volume":"183","author":"Yamagami","year":"2009","journal-title":"J Immunol"},{"key":"10.1038\/jid.2014.291_bb0170","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1172\/JCI44425","article-title":"Homologous regions of autoantibody heavy chain complementarity-determining region 3 (H-CDR3) in patients with pemphigus cause pathogenicity","volume":"120","author":"Yamagami","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2014.291_bb0175","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1084\/jem.20061446","article-title":"Persistent expression of autoantibodies in SLE patients in remission","volume":"203","author":"Yurasov","year":"2006","journal-title":"J Exp Med"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15371396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15371396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T21:51:42Z","timestamp":1743976302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15371396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0022202X15371396"],"URL":"https:\/\/doi.org\/10.1038\/jid.2014.291","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistence of Anti-Desmoglein 3 IgG+ B-Cell Clones in Pemphigus Patients over Years","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2014.291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}